Synapse - Find an Expert

4640 Results

A nutritional management algorithm in older patients with locally advanced esophageal cancer

Journal Article

Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Wu, A. J.; Jones, D. R.; more...
Journal of Geriatric Oncology (2022)

Fulltext@MSK | Save

Hepatic artery infusion pump (HAIP) therapy versus chemotherapy in the first-line setting for patients with unresectable intrahepatic cholangiocarcinoma

Editorial

Rossi, A. J.; Khan, T. M.; Luna, A. J.; Cercek, A.; Jarnagin, W. R.; Hernandez, J. M.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

Factors associated with premature ovarian insufficiency in young women with locally advanced rectal cancer treated with pelvic radiation therapy

Journal Article

Hilal, L.; Cercek, A.; Navilio, J.; Hsu, M.; Zhang, Z.; Brady, P.; Wu, A. J.; Reyngold, M.; Cuaron, J. J.; Romesser, P. B.; more...
Advances in Radiation Oncology (2022)

Fulltext@MSK | Save

Local control and survival after induction chemotherapy and ablative radiation versus resection for pancreatic ductal adenocarcinoma with vascular involvement

Journal Article

Jolissaint, J. S.; Reyngold, M.; Bassmann, J.; Seier, K. P.; Gönen, M.; Varghese, A. M.; Yu, K. H.; Park, W.; O'Reilly, E. M.; Balachandran, V. P.; more...
Annals of Surgery (2021)

Fulltext@MSK | Save

Multiomic biomarker signatures identify subsets of patients who may benefit from either nivolumab or sotigalimab in combination with chemotherapy in metastatic pancreatic cancer

Meeting Abstract

Maurer, D.; Yu, J. X.; Sklodowski, K.; Tognetti, M.; Reiter, L.; Bruderer, R.; Vowinckel, J.; Pfeiffer, S.; O'Hara, M.; O'Reilly, E.; more...
Journal for ImmunoTherapy of Cancer (2021)

Fulltext@MSK | Save

Polo: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer

Meeting Abstract

Arnold, D.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; more...
Oncology Research and Treatment (2021)

Fulltext@MSK | Save

Matterhorn: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - A randomized, doubleblind, placebo-controlled, phase 3 study

Meeting Abstract

Al-Batran, S. E.; Janjigian, Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z.; Hyung, W. J.; Molena, D.; Evans, B.; Ruscica, D.; Robbins, S. H.; more...
Oncology Research and Treatment (2021)

Fulltext@MSK | Save

Spotlight: Phase 3 study of Zolbetuximab+mFOLFOX6 versus placebo+mFOLFOX6 in first-line claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)

Meeting Abstract

Lordick, F.; Shitara, K.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P.; Ilson, D.; Kim, S.; Shah, M. A.; Van Cutsem, E.; more...
Oncology Research and Treatment (2021)

Fulltext@MSK | Save

First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649